• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SMLR

    Semler Scientific Inc.

    Subscribe to $SMLR
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

    IPO Year:

    Exchange: NASDAQ

    Website: semlerscientific.com

    Recent Analyst Ratings for Semler Scientific Inc.

    DatePrice TargetRatingAnalyst
    11/2/2022$60.00 → $45.00Buy → Neutral
    B. Riley Securities
    3/7/2022$145.00 → $70.00Buy
    B. Riley Securities
    11/2/2021$175.00 → $145.00Buy
    B. Riley Securities
    10/26/2021$151.00 → $175.00Buy
    B. Riley Securities
    See more ratings

    Semler Scientific Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Semler Eric was granted 1,318 shares and bought $1,896,500 worth of shares (50,000 units at $37.93), increasing direct ownership by 9% to 621,721 units (SEC Form 4)

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      11/12/24 6:05:40 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Semler Scientific Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Semler Scientific® Announces CardioVanta™, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities

      CAMPBELL, Calif., June 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise its future healthcare business activities focused on early detection of heart failure and cardiac arrythmia monitoring. CardioVanta will be structured as a high-margin, software-as-a-service (SAAS) business model.  It will seek capital from outside investors to validate its long-term value and fund its relatively modest initial capital needs.  The markets for

      6/24/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027

      CAMPBELL, Calif., June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Joe Burnett as director of Bitcoin strategy. Semler Scientific also announced that it plans to hold 10,000 Bitcoins by year-end 2025, 42,000 by year-end 2026 and 105,000 by year-end 2027, using proceeds from equity and debt financings and cash flows from operations.  "We are excited to have Joe join our Bitcoin strategy

      6/19/25 4:45:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Appoints Natalie Brunell to its Board of Directors

      CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci

      5/19/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC

      CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a

      5/13/25 4:01:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 2025 Financial Results

      SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe

      4/30/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 111 BTC; Now Holds 3,303 BTC; YTD BTC Yield of 23.5%

      SANTA CLARA, Calif., April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24, 2025, Semler Scientific acquired 111 bitcoins for $10.0 million with an average purchase price of $90,124 per bitcoin, inclusive of fees and expenses, using p

      4/25/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC

      SANTA CLARA, Calif., Feb. 18, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the fourth quarter and year ended December 31, 2024. "We are again pleased to report strong performance from our healthcare business with income from operations of $20.9 million for the full year 2024," said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific. "While we continue to support innovation and growth

      2/18/25 4:01:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC Activity; Monetizes Minority Investment to Purchase BTC; Purchased Additional 871 BTC; Now Holds 3,192 BTC; YTD BTC Yield of 152.2% Since July 1, 2024

      SANTA CLARA, Calif., Feb. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, and BTC Yield, a key performance indicator. BTC Update Between January 11, 2025 and February 3, 2025, Semler Scientific acquired 871 bitcoins for $88.5 million with proceeds generated from its January 2025 senior convertible notes offering and monetization of a portion of its mi

      2/4/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Pricing of Upsized Offering of $85.0 Million Convertible Senior Notes

      SANTA CLARA, Calif., Jan. 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR) today announced the pricing of its offering of $85.0 million aggregate principal amount of 4.25% convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering size was increased from the previously announced offering size of $75.0 million aggregate principal amount of notes. Semler Scientific also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and includi

      1/24/25 7:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Select Preliminary Unaudited Fourth Quarter 2024 Financial Results and Significant Unrealized Gain from Change in Fair Value of Bitcoin Holdings

      SANTA CLARA, Calif., Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced select preliminary unaudited fourth quarter 2024 financial results and BTC holdings. Semler Scientific will report full financial results for the fourth quarter and full year ended December 31, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Tuesday, February 18, 2025. Select Preliminary Unaudited

      1/23/25 4:02:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Semler Scientific Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Semler Scientific downgraded by B. Riley Securities with a new price target

      B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously

      11/2/22 6:23:13 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • B. Riley Securities reiterated coverage on Semler Scientific with a new price target

      B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $70.00 from $145.00 previously

      3/7/22 10:22:03 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • B. Riley Securities reiterated coverage on Semler Scientific with a new price target

      B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $145.00 from $175.00 previously

      11/2/21 10:00:22 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • B. Riley Securities reiterated coverage on Semler Scientific with a new price target

      B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $175.00 from $151.00 previously

      10/26/21 9:42:58 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Semler Scientific Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Brunell Natalie

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      6/26/25 4:15:11 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Director Semler Eric exercised 6,750 shares at a strike of $23.32, increasing direct ownership by 1% to 636,346 units (SEC Form 4)

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      6/12/25 6:01:48 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Chief Financial Officer Cormier Renae exercised 3,746 shares at a strike of $30.48, gifted 3,746 shares and received a gift of 3,746 shares (SEC Form 4)

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      6/12/25 6:01:01 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Brunell Natalie

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/22/25 6:19:47 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Brunell Natalie

      3 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/22/25 6:18:05 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Cormier Renae

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 9:12:05 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Semler Eric

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 9:10:32 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Chief Executive Officer Murphy-Chutorian Douglas

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 9:09:06 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Messina Daniel S

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 8:56:59 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Chang William H

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 8:25:33 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    Semler Scientific Inc. SEC Filings

    See more
    • Semler Scientific Inc. filed SEC Form 8-K: Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/24/25 8:07:57 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/23/25 4:15:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/20/25 8:00:37 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/4/25 5:00:25 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/4/25 8:00:10 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      5/23/25 8:00:12 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Leadership Update

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      5/19/25 8:03:49 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 10-Q filed by Semler Scientific Inc.

      10-Q - Semler Scientific, Inc. (0001554859) (Filer)

      5/13/25 4:10:57 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      5/13/25 4:05:40 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      5/5/25 8:00:14 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care